131 related articles for article (PubMed ID: 38241819)
1. Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.
Carneiro F; Vinceneux A; Larroquette M; Rony M; Carril L; Laguerre B; Blazevic I; Bartelemy P; Teyssonneau D; Goujon M; Linassier C; Thiery-Vuillemin A; Roubaud G; Mourey L; Albiges L; Gravis G; Gross-Goupil M; Cancel M
Eur J Cancer; 2024 Mar; 199():113534. PubMed ID: 38241819
[TBL] [Abstract][Full Text] [Related]
2. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
Cancel M; Fromont G; Blonz C; Chevreau C; Rioux-Leclercq N; Laguerre B; Oudard S; Gross-Goupil M; Gravis G; Goldwasser F; Rolland F; Delva R; Moise L; Emambux S; Vassal C; Zanetta S; Penel N; Fléchon A; Barthélémy P; Saldana C; Lefort F; Escudier B; Linassier C; Albiges L
Eur J Cancer; 2021 Oct; 158():1-11. PubMed ID: 34619467
[TBL] [Abstract][Full Text] [Related]
3. Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study.
Guillot A; Joly C; Barthélémy P; Meriaux E; Negrier S; Pouessel D; Chevreau C; Mahammedi H; Houede N; Roubaud G; Gravis G; Tartas S; Albiges L; Vassal C; Oriol M; Tinquaut F; Espenel S; Bouleftour W; Culine S; Fizazi K
Clin Genitourin Cancer; 2019 Feb; 17(1):e38-e43. PubMed ID: 30279115
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
Maelle R; Jean-Philippe R; Jochen W; Geraldine P; Fabrice C; Christian P; Mathilde G; Slimane D; Serge B; Naji S; Cecile V; Stanislas R; Thomas M; Sami F; Manuel T; Marc G; Gwenaelle G
Front Oncol; 2021; 11():644301. PubMed ID: 33833995
[No Abstract] [Full Text] [Related]
5. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.
Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E
World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955
[TBL] [Abstract][Full Text] [Related]
6. Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.
Belkacemi Y; Latorzeff I; Hasbini A; Coraggio G; Pasquier D; Toledano A; Hennequin C; Bossi A; Chapet O; Crehange G; Guerif S; Duberge T; Allouache N; Clavere P; Gross E; Supiot S; Azria D; Bolla M; Sargos P
Cancer Radiother; 2020 Dec; 24(8):892-897. PubMed ID: 33144063
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
Vinault S; Mariet AS; Le Bras M; Mirallié E; Cardot-Bauters C; Pattou F; Ruszniewski P; Sauvanet A; Chanson P; Baudin E; Elias D; Menegaux F; Gaujoux S; Borson-Chazot F; Lifante JC; Caron P; Carrère N; Tabarin A; Laurent C; Klein M; Brunaud L; Niccoli P; Sebag F; Cadiot G; Kianmanesh R; Luu M; Binquet C; Goudet P
Ann Surg; 2020 Dec; 272(6):1094-1101. PubMed ID: 30585820
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
9. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.
Oudard S; Banu E; Vieillefond A; Fournier L; Priou F; Medioni J; Banu A; Duclos B; Rolland F; Escudier B; Arakelyan N; Culine S;
J Urol; 2007 May; 177(5):1698-702. PubMed ID: 17437788
[TBL] [Abstract][Full Text] [Related]
10. Metastatic renal cell carcinoma to pancreas and gastrointestinal tract: a clinicopathological study of 3 cases and review of literature.
Abdul-Ghafar J; Ud Din N; Saadaat R; Ahmad Z
BMC Urol; 2021 May; 21(1):84. PubMed ID: 34034720
[TBL] [Abstract][Full Text] [Related]
11. Case report: Uncommon gastric metastasis as a presentation of recurrent clear cell renal cell carcinoma.
Sabaté-Ortega J; Albert-Carrasco M; Escribano-Ferrer C; Grau-Manrubia G; Fina-Planas C; López-Núñez C; Teixidor-Vilà E; Bujons-Buscarons E; Montañés-Ferrer C; Sala-González N
Front Oncol; 2024; 14():1354127. PubMed ID: 38807761
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
Goudet P; Murat A; Binquet C; Cardot-Bauters C; Costa A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Delemer B; Beckers A; Bonithon-Kopp C
World J Surg; 2010 Feb; 34(2):249-55. PubMed ID: 19949948
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.
Meyer E; Pasquier D; Bernadou G; Calais G; Maroun P; Bossi A; Theodore C; Albiges L; Stefan D; de Crevoisier R; Hennequin C; Lagrange JL; Grellard JM; Clarisse B; Licaj I; Habrand JL; Carrie C; Joly F
Eur J Cancer; 2018 Jul; 98():38-47. PubMed ID: 29864737
[TBL] [Abstract][Full Text] [Related]
15. [Gastric or duodenal metastases from clear cell renal cell carcinoma. Report of two cases and review of the literature].
Haffner J; Morel JF; Maunoury V; Caty A; Biserte J; Villers A
Prog Urol; 2007 Nov; 17(7):1305-9. PubMed ID: 18271411
[TBL] [Abstract][Full Text] [Related]
16. Duodenal bleeding from metastatic renal cell carcinoma.
Rustagi T; Rangasamy P; Versland M
Case Rep Gastroenterol; 2011 Apr; 5(1):249-57. PubMed ID: 21577373
[TBL] [Abstract][Full Text] [Related]
17. Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.
Blanchard P; Faivre L; Lesaunier F; Salem N; Mesgouez-Nebout N; Deniau-Alexandre E; Rolland F; Ferrero JM; Houédé N; Mourey L; Théodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Davin JL; Habibian M; Culine S; Laplanche A; Fizazi K
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):85-92. PubMed ID: 26576711
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases.
Zhai J; Liu N; Wang H; Huang G; Man L
Front Oncol; 2021; 11():659779. PubMed ID: 34221976
[TBL] [Abstract][Full Text] [Related]
19. Gastric fundic gland metastasis of renal cell carcinoma 14 years after the primary diagnosis.
Degerli MS; Karayagiz AH
J Cancer Res Ther; 2022; 18(6):1801-1803. PubMed ID: 36412447
[TBL] [Abstract][Full Text] [Related]
20. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
